UNSPSC 51172004: Dimethyl sulfoxide

This classification denotes a sulfur compound with the molecular formula C2H6OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YOW8V9698H, chemically known as sulfoxide, dimethyl but generally known as dimethyl sulfoxide, which bears US NIH Compound Identifier 679. European Medicines Agency schedules Dimethyl sulfoxide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07176MIG.

UNSPSC 51172004 Dimethyl sulfoxide is a Commodity code that nominally covers a single chemical compound, but recent state and local solicitations under this code show little activity directly aligned with the product itself. The code appears in procurement records primarily as a misattributed or catch-all tag for broader pharmaceutical, laboratory testing, and specimen-collection services rather than as a signal for standalone dimethyl sulfoxide procurement. State and local agencies soliciting under this code span criminal justice departments, health and human services commissions, and cooperative purchasing alliances administering multistate pharmaceutical contracts. When activity does surface, issuing bodies include county corrections and community supervision departments, state health agencies, and state procurement offices managing cooperative agreements for multiple jurisdictions.

The most recent opportunities show no focused geographic concentration and span three distinct service categories unrelated to the chemical product. Collin County Community Supervision and Corrections Department posted RFP 2026-327 on July 9, 2026, requesting offender specimen collection and drug testing services with proposals due July 23, 2026—an estimated contract value of $600,000 over two years with three optional one-year renewals, covering immunoassay screening, LC/MS/MS or GC/MS confirmation testing, and alternative methodologies including oral fluid and hair testing at two collection sites in Plano and McKinney. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to solicit vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program—an exploratory information-gathering phase with no award value disclosed. The Minnesota Department of Administration's Office of State Procurement, administering the MMCAP cooperative purchasing alliance, posted RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities, with proposals due March 26, 2026 and evaluation weighted 75 percent on price competitiveness. The code shows minimal recent relevance to state and local procurement of dimethyl sulfoxide as a standalone product or chemical input.